Company Filing History:
Years Active: 2007-2011
Title: Doug Hodgins: Innovator in Modified Leukotoxin Research
Introduction
Doug Hodgins is a notable inventor based in Milverton, CA. He has made significant contributions to the field of biotechnology, particularly in the development of modified leukotoxin proteins. With a total of three patents to his name, Hodgins is recognized for his innovative approaches to vaccine compositions effective against various animal diseases.
Latest Patents
Hodgins' latest patents focus on the modified leukotoxin gene and protein. The first patent provides nucleic acid sequences encoding a modified leukotoxin protein, which involves the removal of nucleic acid sequences that encode amino acids within hydrophobic transmembrane domains of the full-length leukotoxin protein. This modification enhances the utility of the modified leukotoxin proteins in vaccine compositions aimed at animals. The second patent mirrors the first, emphasizing the same modifications and applications.
Career Highlights
Doug Hodgins is affiliated with the University of Guelph, where he conducts his research and development work. His academic background and ongoing research contribute to advancements in veterinary medicine and immunology. Hodgins' work is pivotal in creating effective vaccine solutions that can improve animal health.
Collaborations
Some of Hodgins' notable coworkers include Patricia E. Shewen and Raymond W. H. Lee. Their collaborative efforts in research have furthered the understanding and application of modified leukotoxin proteins in vaccine development.
Conclusion
In summary, Doug Hodgins is a prominent inventor whose work on modified leukotoxin proteins has the potential to revolutionize vaccine compositions for animals. His contributions to the field are invaluable and continue to inspire further research and innovation.